Minor P - Search Results

1

WHO working group meeting to amend WHO Recommendations to assure the quality, safety and efficacy of live attenuated yellow fever vaccines.

Martin J, Barrett ADT, Lei D, Minor P. Martin J, et al. Among authors: minor p. Vaccine. 2022 Jun 9;40(26):3490-3494. doi: 10.1016/j.vaccine.2022.04.095. Epub 2022 May 9. Vaccine. 2022. PMID: 35550848 Free PMC article.

2

WHO Working Group discussion on revision of the WHO recommendations for the production and control of poliomyelitis vaccines (oral): TRS Nos. 904 and 910. Report of Meeting held on 20-22 July 2010, Geneva, Switzerland.

Martin J, Milne C, Minor P, Chumakov K, Baca-Estrada M, Caruana JF, Zhou T; WHO Working Group. Martin J, et al. Among authors: minor p. Vaccine. 2011 Sep 2;29(38):6432-6. doi: 10.1016/j.vaccine.2011.06.079. Epub 2011 Jul 3. Vaccine. 2011. PMID: 21729731

3

WHO Working Group on Technical Specifications for Manufacture and Evaluation of Yellow Fever Vaccines, Geneva, Switzerland, 13-14 May 2009.

Ferguson M, Shin J, Knezevic I, Minor P, Barrett A; WHO Working Group. Ferguson M, et al. Among authors: minor p. Vaccine. 2010 Dec 6;28(52):8236-45. doi: 10.1016/j.vaccine.2010.10.070. Epub 2010 Nov 4. Vaccine. 2010. PMID: 21055492 Free PMC article.

4

Differences in Antigenic Structure of Inactivated Polio Vaccines Made From Sabin Live-Attenuated and Wild-Type Poliovirus Strains: Impact on Vaccine Potency Assays.

Crawt L, Atkinson E, Tedcastle A, Pegg E; sIPV Study Group; Minor P, Cooper G, Rigsby P, Martin J. Crawt L, et al. Among authors: minor p. J Infect Dis. 2020 Feb 3;221(4):544-552. doi: 10.1093/infdis/jiz076. J Infect Dis. 2020. PMID: 30788503

5

Characterization of CHAT and Cox type 1 live-attenuated poliovirus vaccine strains.

Martín J, Minor PD. Martín J, et al. J Virol. 2002 Jun;76(11):5339-49. doi: 10.1128/jvi.76.11.5339-5349.2002. J Virol. 2002. PMID: 11991962 Free PMC article.

6

High resolution identity testing of inactivated poliovirus vaccines.

Mee ET, Minor PD, Martin J. Mee ET, et al. Vaccine. 2015 Jul 9;33(30):3533-41. doi: 10.1016/j.vaccine.2015.05.052. Epub 2015 Jun 3. Vaccine. 2015. PMID: 26049003 Free PMC article.

7

Comparison of the nucleotide and deduced amino acid sequences of the structural protein genes of the yellow fever 17DD vaccine strain from Senegal with those of other yellow fever vaccine viruses.

Jennings AD, Whitby JE, Minor PD, Barrett AD. Jennings AD, et al. Among authors: minor pd. Vaccine. 1993;11(6):679-81. doi: 10.1016/0264-410x(93)90317-q. Vaccine. 1993. PMID: 8322493

8

Comparison of the nucleotide and deduced amino acid sequences of the envelope protein genes of the wild-type French viscerotropic strain of yellow fever virus and the live vaccine strain, French neurotropic vaccine, derived from it.

Jennings AD, Whitby JE, Minor PD, Barrett AD. Jennings AD, et al. Among authors: minor pd. Virology. 1993 Feb;192(2):692-5. doi: 10.1006/viro.1993.1090. Virology. 1993. PMID: 8421909

9

Interaction of yellow fever virus French neurotropic vaccine strain with monkey brain: characterization of monkey brain membrane receptor escape variants.

Ni H, Ryman KD, Wang H, Saeed MF, Hull R, Wood D, Minor PD, Watowich SJ, Barrett AD. Ni H, et al. Among authors: minor pd. J Virol. 2000 Mar;74(6):2903-6. doi: 10.1128/jvi.74.6.2903-2906.2000. J Virol. 2000. PMID: 10684309 Free PMC article.

10

Yellow fever 17DD vaccine virus is temperature sensitive when grown in mosquito C6-36 cells.

Ledger TN, Sil BK, Dunster LM, Stephenson JR, Minor PD, Barrett AD. Ledger TN, et al. Among authors: minor pd. Vaccine. 1992;10(10):652-4. doi: 10.1016/0264-410x(92)90084-w. Vaccine. 1992. PMID: 1523874

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

348 results

Search Page

Filters